"The ERA-EDTA meeting is less than 3 weeks away, at which there is rumored to be a symposium on BET inhibitors and Renal Disease sponsored by Resverlogix. Nothing official from Resverlogix on this yet, but hopefully it comes to fruition. It would be very timely with the IND/FDA approval of the renal trial happening yesterday."

I found it: 

Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?

https://agoracom.com/ir/Resverlogix/forums/discussion/topics/690408-managing-ckd-diabetes-cvd-is-epigenetics-a-new-way-forward/messages/2151236#message